Greater waist circumference (WC) may be a useful predictor for elevated blood pressure (BP) in children and adolescents, according to a study presented at the 13th Asian-Pacific Congress of Hypertension held in Singapore.
Increasing evidence points to a link between hypertension and cognitive decline, particularly in the elderly population, according to a presentation at APCH 2017. However, the impact of antihypertensive medication use on dementia incidence is unestablished.
For stroke prevention in an Asian population, a blood pressure (BP) of <140/90 mm Hg is a reasonable target and particularly, 120-130/80 mm Hg may be optimal, according to a presentation at the APCH 2017 Meeting in Singapore.
The efficacy and cardiovascular (CV) safety of the SGLT2* inhibitor empagliflozin vs DPP-4** inhibitors and GLP-1*** receptor agonists in real-world patients were demonstrated in two interim analyses of the EMPRISE+ study presented at ADA 2020.
Patients hospitalized with mild-to-moderate COVID-19 who are on angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) for hypertension should continue these medications, according to primary results of the BRACE CORONA trial presented at ESC 2020.
Early initiation of rhythm-control therapy led to a significantly reduced risk of major adverse cardiovascular (CV) outcomes compared with usual care (typically rate control) in patients with newly diagnosed atrial fibrillation (AF) at risk of stroke, reveals the EAST-AFNET 4* trial presented at ESC 2020.